Arthroscopy Instruments Market - By Product Type, By Application, By Usability, By End Use - Global Forecast, 2025 - 2034

Arthroscopy Instruments Market Size

The global arthroscopy instruments market was estimated at USD 6.5 billion in 2024. The market is expected to grow from USD 6.7 billion in 2025 to USD 9.4 billion in 2034, growing at a CAGR of 3.9%. The market for arthroscopy instruments is driven primarily by the increasing incidence of sports injuries, growing preference for minimally invasive surgeries, technological advancements with visualization and powered systems, increasing an aging population with joint disorders, increasing number of ambulatory surgical centers for outpatient surgeries and shift towards disposable arthroscopic implements.
 

Arthroscopy instruments are dedicated tools used in minimally invasive surgical procedures to identify and treat joint conditions. Significant players include Stryker, Smith & Nephew, Arthrex, Olympus, and Karl Storz. The market remains to grow due to rising sports injuries and orthopedic procedures.
 

The market reached from USD 6.3 billion in 2021 to USD 6.4 billion in 2023, registering a CAGR growth of 1.2% during this period. The growth of the industry is mainly driven by the rising prevalence of joint disorders, increasing demand for minimally invasive surgical procedures, and growing participation in sports activities leading to a higher incidence of injuries. Developments in arthroscopic technology, counting high-definition imaging and precision instruments, have added enhanced surgical outcomes, encouraging wider adoption among orthopedic surgeons and increasing overall market expansion.
 

The rise in joint disorders and sports injuries are several other key drivers which are fueling the growth of the arthroscopy instruments market. A significant factor is the aging global population. For instance, according to WHO, by 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). The number of people aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. This will result in increasing the prevalence of degenerative joint diseases such as osteoarthritis. Consequently, demand for joint-preserving procedures like arthroscopy is increasing.
 

Additionally, growing awareness about early diagnosis and treatment of joint-related issues is promoting the use of arthroscopic techniques. The increasing preference for outpatient and ambulatory surgical centers is another driver, as arthroscopy enables quicker recovery, minimal scarring, and reduced hospital stays, aligning with the global shift toward value-based care.
 

Technological advancements have also played a pivotal role. For instance, the integration of robotics and AI in arthroscopy, such as Stryker’s Mako SmartRobotics platform, enhances precision and clinical outcomes. Moreover, the development of disposable arthroscopic instruments has lowered the risk of cross-contamination and maintenance costs, making them attractive for healthcare facilities. The rising healthcare expenditure in emerging economies is enabling more widespread adoption of arthroscopy procedures.
 

Additionally, favorable reimbursement policies in developed countries support the affordability of arthroscopic procedures. In the U.S., Medicare and private insurers cover most arthroscopic surgeries, encouraging both patients and providers to opt for these minimally invasive interventions.
 

Arthroscopy instruments are specialized surgical power tools used in minimally invasive procedures to diagnose and treat joint-related conditions, such as ligament tears or cartilage damage. These instruments include arthroscopes, shavers, graspers, and fluid management systems, allowing surgeons to view, access, and operate within joints like the knee, shoulder, or hip through small incisions, reducing recovery time and complications.
 

Arthroscopy Instruments Market Trends

The market for arthroscopy instruments is facing a remarkable transition, influenced by both macro and micro trends. From the macro level, the aging global population and increasing incidence of musculoskeletal conditions are underpinning long-term demand for minimally invasive joint procedures.
 

• Furthermore, musculoskeletal problems are found to affect >1.7 billion people globally and are driving the increasing use of arthroscopy. A rising emphasis on value-based healthcare also is impacting purchasing decisions with hospitals proactively looking for cost-effective, outcome-oriented solutions that can connect into the patient’s user experience in the consumer space.
   
• On a micro level, there are several significant tech developments that are transforming arthroscopy. New arthroscopy systems also now feature 4K and 3D images, providing a more accurate means of surgery for surgeons. Robotics systems (e.g., Stryker’s Mako) for arthroscopy are attracting attention for their precision in joint resurfacing and minimally invasive repair.
   
• Artificial intelligence and machine learning in arthroscopy imaging is also an up-and-coming trend, with the aid of div diagnostic and interventional planning. Furthermore, the development of wireless and battery-powered handheld arthroscopic devices offers increased portability and ease of use in outpatient settings.
   
• Product evolution is another key trend, with manufacturers focusing on disposable and single-use arthroscopy instruments to reduce infection risks, eliminate sterilization costs, and improve surgical efficiency. Companies are also investing in ergonomic designs and multifunctional tools that combine multiple functions into one device, thereby reducing instrument exchanges and procedure time.
   
• From a regulatory perspective, stricter safety and performance standards by agencies such as the U.S. FDA and European Medicines Agency are pushing manufacturers to innovate while ensuring compliance. The implementation of the EU Medical Device Regulation (MDR) has particularly impacted on design and documentation processes, encouraging higher quality and transparency.
   
• In terms of manufacturing, there’s a shift toward precision engineering using advanced materials like titanium and carbon composites, alongside adoption of additive manufacturing (3D printing) for rapid prototyping and custom instrumentation. Collectively, these trends are shaping a highly competitive and innovation-driven market, poised for steady growth in the coming years.
   

Arthroscopy Instruments Market Analysis

The market reached from USD 6.2 billion in 2021 to USD 6.4 billion in 2023, driven by rising sports injuries and increasing adoption of minimally invasive surgical procedures worldwide.  
 

Based on the product type, the arthroscopy instruments market is segmented into powered shaver systems, visualization systems, arthroscopes, fluid management systems, arthroscopic implants, radiofrequency (RF) ablation systems, and other product types. The powered shaver systems segment accounted for 23.9% of the market in 2024 driven by their critical role in precise tissue resection and improved procedural efficiency during arthroscopic surgeries. The segment is expected to exceed USD 2.4 billion by 2034, growing at a CAGR of 4.6% during the forecast period. On the other hand, arthroscopic implants segment is expected to grow with a CAGR of 4.9%. The growth of this segment can be attributed to the continuous advancements in biomaterials and implant design, enhancing surgical outcomes and durability.
 

• The powered shaver system segment is dominant due to it is demand for effective soft tissue and bone resection during minimally invasive surgeries. They increase precision, decrease the operation time and improve the surgical results. These systems enhance accuracy, lower the operation time, and improve the surgical success of joint surgeries. Their ease of use and compatibility with visualization systems, and an increasing adoption in outpatient arthroscopic surgeries are other factors propelling growth. The estimated growth of the segment is due to the rising surgeon preference for the use of these sutures as well as the increase in procedural volumes based on geography.
   
• The second-largest segment, visualization systems, held a market share of 21.6% in 2024, due to its critical role in efficient tissue debridement and precise bone sculpting during joint procedures. These systems enhance surgical accuracy and reduce operative time. The segment is driven by increased demand for minimally invasive surgeries and continuous technological innovations in motorized shaver blade designs and control consoles.
   
• The arthroscopic implants segment, though smaller with a market share of 11.8%, is expected to grow at a CAGR of 4.9%, driven by the increasing demand for minimally invasive joint repair, advancements in bioabsorbable materials, and rising sports-related injuries. Its high CAGR reflects the growing adoption of innovative implant designs that enhance joint stability and post-surgical outcomes.
   

Based on the application, the arthroscopy instruments market is segmented into knee arthroscopy, shoulder arthroscopy, hip arthroscopy, and other applications. The knee arthroscopy segment accounted for the highest market share of 41.6% in 2024 driven by the high prevalence of sports injuries and osteoarthritis requiring minimally invasive surgical interventions.
 

• The segment holds the major market share due to the high incidence of knee-related injuries, mainly among athletes and aging individuals suffering from osteoarthritis. Increasing participation in sports and physical activities upsurges the risk of ligament tears and meniscal injuries, which are usually treated via arthroscopy. In addition, developments in arthroscopic techniques and faster recovery times have made it the favored surgical option for knee joint diagnosis and treatment.
   
• The second-largest segment, shoulder arthroscopy, held a market share of 30% in 2024, due to the increasing incidence of rotator cuff injuries, dislocations, and arthritis-related conditions, particularly among athletes and the elderly. Advancements in imaging technologies and minimally invasive techniques have improved surgical outcomes, boosting demand. Additionally, rising outpatient procedures support the segment’s strong position in the market.
   

Based on usability, the arthroscopy instruments market is bifurcated into reusable arthroscope, and disposable arthroscopes. The reusable arthroscope segment accounted for the highest market share of 84.3% in 2024 driven by its cost-effectiveness, durability, and widespread adoption in high-volume surgical settings.
 

• The reusable arthroscope segment holds a dominant market share due to its long-term cost efficiency and robust build, making it ideal for repeated use in hospitals and surgical centers. Its high image resolution, compatibility with advanced imaging systems, and reduced per-procedure cost make it a preferred choice in high-volume surgical environments.
   
• Additionally, established sterilization protocols and investments in high-quality equipment by healthcare facilities further drives its widespread adoption.
   
• The disposable arthroscopes segment, though smaller with a market share of 15.8%, is expected to grow at a CAGR of 4.8%, due to rising concerns over cross-contamination and infection risks associated with reusable devices. These single-use instruments eliminate the need for sterilization, reduce turnaround time between procedures, and minimize maintenance costs.
   
• Hospitals and ambulatory surgical centers increasingly prefer disposable options to enhance workflow efficiency and patient safety. Additionally, advancements in low-cost, high-quality disposable optics are boosting adoption, contributing to the segment's high CAGR.

Based on the end use, the arthroscopy instruments market is segmented into hospitals, ambulatory surgical centers, and other end users. The hospitals segment accounted for the highest market share of 61% in 2024 driven by the high volume of arthroscopic procedures performed in these settings due to advanced infrastructure and availability of skilled professionals.
 

• The top two end use segments represent 86.8% of total market value. Among them, hospital segment leads owing to their comprehensive surgical infrastructure, access to innovative imaging technologies, and availability of trained orthopedic surgeons. These amenities often serve as referral centers for complex joint surgeries, handling a higher volume of patients.
   
• In addition, hospitals naturally receive greater reimbursement funding and are well equipped for post-operative care, making them the favored choice for both patients and surgeons, thereby acquiring a leading market share.
   
• The ambulatory surgical centers segment, though smaller with a market share of 25.8%, is expected to grow at a CAGR of 4.5%, because of the growing need for orthopedic procedures that are both economical and time efficient. Compared to traditional hospitals, ASCs provide quicker recovery times, lower surgical costs, and shorter hospital stays.
   
• The growing preference for outpatient care, coupled with advancements in arthroscopic technologies that enable same-day discharge, is accelerating their adoption. Additionally, favorable reimbursement policies and improved infrastructure in ASCs are contributing to the segment's high CAGR.

North America dominated the global arthroscopy instruments market with the highest market share of 35.3% in 2024.
 

• The U.S. market was valued at 2.167 billion and USD 2.169 billion in 2021 and 2022, respectively. In 2024 the market size reached USD 2.191 billion from USD 2.174 billion in 2023. The growth is driven by rising sports injuries and increased adoption of minimally invasive surgical techniques. Technological advancements and strong healthcare infrastructure further support consistent market expansion.
   
• North America's supremacy in the global arthroscopy instruments market is principally attributed to its innovative healthcare infrastructure, primary adoption of innovative surgical technologies, and a high volume of orthopedic surgeries. The region has a well-established network of specialized orthopedic centers and ambulatory surgical facilities, which promote the widespread use of minimally invasive techniques.
   
• Moreover, the growing geriatric population, coupled with the rising prevalence of osteoarthritis and sports-related injuries, contributes to the steady demand for arthroscopic procedures. North America also benefits from a strong reimbursement framework, encouraging both providers and patients to opt for advanced treatment options. Strategic investments by leading medical device manufacturers in research and development, along with ongoing surgeon training programs, further drive the regional market.
   
• In the U.S., market growth is propelled by increasing participation in sports and fitness activities, resulting in a higher incidence of musculoskeletal injuries. Additionally, the availability of skilled surgeons, rising patient awareness, and continuous technological innovations, such as high-definition imaging systems and robotic-assisted arthroscopy support the sustained growth of the market.
   

Europe arthroscopy instruments market accounted for USD 1.6 billion in 2024.
 

• The industry is driven by the region's developed healthcare infrastructure, growing elderly population, and rising demand for minimally invasive surgical surgeries. The growing prevalence of osteoarthritis, rheumatoid arthritis, and sports-related injuries has suggestively increased the demand for arthroscopic surgeries. According to the European League Against Rheumatism (EULAR), over 300 million people globally suffer from osteoarthritis, of these, more than 40 million adults live in Europe.
   
• Additionally, favorable reimbursement policies and government initiatives to promote advanced surgical technologies have encouraged hospitals and clinics to adopt arthroscopic techniques. The presence of major industry players and a strong focus on research and development for technological innovations in imaging systems, surgical navigation, and precision tools are also boosting market growth.
   
• Furthermore, the increasing popularity of ambulatory surgical centers and outpatient procedures in countries like France, Italy, and the UK supports the demand for efficient and cost-effective arthroscopy instruments.
   
• In Germany, market growth is driven by its robust orthopedic care infrastructure, a high number of trained arthroscopic surgeons, and extensive insurance coverage. The country also sees a high volume of sports-related injuries, contributing to greater arthroscopy procedure rates. Germany’s emphasis on early intervention and minimally invasive solutions further supports arthroscopy instrument demand.
   

The Asia Pacific arthroscopy instruments market is anticipated to witness high growth over the analysis timeframe.
 

• Rising healthcare expenditure, expanding medical tourism, and increasing awareness of minimally invasive procedures are major contributors. Countries like India, Japan, and South Korea are witnessing a surge in sports injuries and orthopedic disorders due to sedentary lifestyles and aging populations. Government initiatives to upgrade healthcare infrastructure and promote advanced surgical techniques are encouraging hospitals to adopt arthroscopy equipment.
   
• Moreover, the increasing number of ambulatory surgical centers and orthopedic clinics across urban and semi-urban regions is enhancing accessibility to arthroscopic procedures. The availability of cost-effective labor and favorable regulations has attracted key global players to set up manufacturing units in the region, improving supply chains and reducing product costs.
   
• Additionally, a growing number of skilled orthopedic surgeons trained in arthroscopic methods is further supporting regional market expansion.
   
• In China, market growth is driven by a large aging population, increasing cases of osteoarthritis, and government investments in public health infrastructure. The Healthy China 2030 initiative aims to strengthen healthcare services, which includes the adoption of advanced surgical technologies. China's booming medical device manufacturing sector, supported by regulatory reforms and incentives for innovation, is also propelling the domestic production of arthroscopy instruments.
   

The Latin America arthroscopy instruments market is anticipated to witness high growth over the analysis timeframe.
 

• The region’s market is projected to grow significantly owing to the rising healthcare investments, expanding access to minimally invasive procedures, and an increasing burden of musculoskeletal conditions. With aging demographics and a growing prevalence of osteoarthritis, mainly in urban regions, the demand for advanced orthopedic treatments is escalating.
   
• According to the Pan American Health Organization, non-communicable diseases, including musculoskeletal disorders, are a leading cause of disability in the region. Moreover, rising sports participation and related injuries have led to increased use of arthroscopy for quicker recovery and better outcomes.
   
• Technological advancements and wider training access for orthopedic surgeons are also contributing to regional growth. Furthermore, improvements in healthcare infrastructure and a gradual shift toward ambulatory and outpatient procedures are increasing the adoption of arthroscopic techniques.
   
• In Brazil, the largest healthcare market in Latin America, growth is driven by rising public and private healthcare expenditure, increasing awareness of minimally invasive surgery, and government efforts to modernize healthcare services.
   

Arthroscopy Instruments Market Share

Leading companies like Stryker, Smith & Nephew, Arthrex, Olympus, and Karl Storz together hold between 55% of the market share in the moderately consolidated global market. This absorption indicates a competitive yet controlled landscape, where a few leading players leverage technological proficiency, strong distribution links, and reputable brand recognition to maintain their leadership positions. These companies consistently invest in research and development to introduce innovative, user-friendly, and precision-based instruments that align with the growing demand for minimally invasive surgeries. Their dominance is also reinforced by frequent mergers, acquisitions, and strategic collaborations aimed at expanding their geographic reach and product portfolios.
 

Mid-sized and emerging companies, though holding smaller shares individually, are increasingly gaining ground by offering cost-effective alternatives and targeting niche segments or emerging markets with high growth potential. This diversification of players ensures a steady pace of innovation and prevents monopolistic tendencies. Additionally, localized manufacturers, especially in the Asia Pacific and Latin America regions, are growing in prominence due to their ability to cater to regional demands with affordable, regulatory-compliant solutions.
 

The market structure promotes a balanced competitive environment where established companies set benchmarks in quality and innovation, while new entrants foster pricing competitiveness and localized service offerings. Furthermore, the trend of integrating digital technologies, robotics, and AI into arthroscopy systems is accelerating partnerships between medical device firms and software companies, gradually shifting the market toward smart surgical platforms. As hospitals and ambulatory centers continue to prioritize surgical efficiency and patient outcomes, companies offering comprehensive service models-spanning instrument supply, surgeon training, and post-operative support-are likely to gain a strategic edge. The market’s moderate consolidation reflects a dynamic equilibrium between dominance by global giants and the rising presence of innovative challengers.
 

Arthroscopy Instruments Market Companies

Few of the prominent players operating in the arthroscopy instruments industry include:

• Arthrex
• B. Braun
• CONMED
• DePuy Synthes (J&J)
• Hemodia
• Invamed
• Karl Storz
• Medacta
• Medtronic
• Olympus
• Richard Wolf
• Smith & Nephew
• Stryker
• Zimmer Biomet
   
• Stryker

Stryker stands out for its advanced arthroscopy solutions integrated with digital imaging, navigation, and minimally invasive systems. The company’s Mako SmartRobotics and 4K visualization tools enhance surgical precision. Its global reach, strong research and development investment, and comprehensive orthopedic portfolio make it a preferred choice for hospitals and ambulatory centers worldwide.
 

• Smith & Nephew

Smith & Nephew excels in sports medicine and arthroscopy with a focus on biologics, repair systems, and efficient fluid management. Its innovative technologies, such as COBLATION and advanced suturing devices, enhance minimally invasive joint procedures. The company’s global training programs support surgeon education and clinical adoption, strengthening market presence.
 

• Arthrex

Arthrex is renowned for its surgeon-driven innovation in arthroscopy, offering over 13,000 products for minimally invasive orthopedic surgery. Its continuous development of next-generation implants and instruments, combined with in-house medical education centers, positions it as a market leader known for responsiveness to clinical needs and outstanding customer support.
 

• Olympus

Olympus leverages its core strength in optical and imaging technologies to deliver high-definition arthroscopic visualization systems. The company’s focus on precision, ergonomic design, and integrated digital solutions supports efficient diagnosis and treatment. Olympus’s global infrastructure and innovation in minimally invasive tools make it a strong player in the arthroscopy space.
 

Arthroscopy Instruments Industry News:

• In April 2023, Stryker partnered with Project C.U.R.E. to deliver medical equipment and supplies to underserved communities in 135 countries. This collaboration supports global healthcare equity and reinforces Stryker’s commitment to improving access to essential surgical tools and technologies, including those used in arthroscopic and orthopedic procedures.
   
• In March 2023, Zimmer Biomet announced the upcoming launch of ZBEdge, a digital ecosystem combining robotic, data analytics, and smart implant technologies. The integrated platform aims to streamline surgical workflows, enhance clinical decision-making, and improve outcomes across orthopedic procedures, including arthroscopy and joint replacements.
   
• In March 2023, Smith + Nephew introduced Precise in Motion, a groundbreaking arthroscopy innovation leveraging artificial intelligence to personalize surgeries. The solution is designed to boost surgical efficiency, improve performance, and support better patient outcomes by offering data-driven insights and enhanced procedural control to orthopedic surgeons.
   
• In January 2023, Arthrex, Inc. received FDA clearance for its TightRope device, marking it as the only approved implant for pediatric ACL reconstruction. This milestone underscores Arthrex’s leadership in orthopedic innovation and commitment to addressing specific surgical needs in younger patient populations with advanced, minimally invasive solutions.
   

The arthroscopy instruments market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Powered shaver systems
• Visualization systems
• Arthroscopes
• Fluid management systems
• Arthroscopic implants
• Radiofrequency (RF) ablation systems
• Other product types

Market, By Application

• Knee arthroscopy
• Shoulder arthroscopy
• Hip arthroscopy
• Other applications

Market, By Usability

• Reusable arthroscope
• Disposable arthroscopes

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE